[1]STERLING RK, LISSEN E, CLUMECK N, et al.Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection[J].Hepatology, 2006, 43 (6) :1317-1325.
|
[2] HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176.
|
[3]ALVAREZ F, BERG PA, BIANCHI FB, et al.International Autoimmune Hepatitis Group Report:review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol, 1999, 31 (5) :929-938.
|
[4]CZAJA AJ.Performance parameters of the diagnostic scoring systems for autoimmune hepatitis[J].Hepatology, 2008, 48 (5) :1540-1548.
|
[5]Chinese Society of Infectious Diseases and Parasitology, Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会, 肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
|
[6]KRAWITT EL.Autoimmune hepatitis[J].N Engl J Med, 2006, 354 (1) :54-66.
|
[7]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
|
[8]QIU D, WANG Q, WANG H, et al.Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J].J Hepatol, 2011, 54 (2) :340-347.
|
[9]MANNS MP, CZAJA AJ, GORHAM JD, et al.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.
|
[10]PUOTI C, BELLIS L, GUARISCO R, et al.HCV carriers with normal alanine aminotransferase levels:healthy persons or severely ill patients?Dealing with an everyday clinical problem[J].Eur J Intern Med, 2010, 21 (2) :57-61.
|
[11]FREDERIK CK, CAROLINE RD, MARTIN KI, et al.APRI:a simple bedside marker for advanced fibrosis that can avoide liver biopsy in patients with NAFLD/NASH[J].S Afr Med J, 2011, 101 (7) :477-480.
|
[12]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for hepatitis C:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1961-1979. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.丙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1961-1979.
|
[13]JIN WW, LIN ZH, XIN YN, et al.Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related significant fibrosis:a meta-analysis[J].J Pract Med, 2011, 27 (5) :797-799. (in Chinese) 金文文, 林中华, 辛永宁, 等.APRI指数诊断HBV相关显著肝纤维化准确性的Meta分析[J].实用医学杂志, 2011, 27 (5) :797-799.
|
[14]MALLET V, DHALLUIN-VENIER V, ROUSSIN C, et al.The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B[J].Aliment Pharmacol Ther, 2009, 29 (4) :409-415.
|